(Q48912488)

English

Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.

scientific article published in March 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

major depressive disorder

1 reference

based on heuristic

inferred from title

author name string

J E Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

S J Yoon

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

J Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

J Y Jung

4

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

H S Jeong

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

H B Cho

6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

E Shin

7

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

I K Lyoo

8

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

T S Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

International Journal of Clinical Practice

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

65

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

323-329

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Anxious depressions. Clinical, family history, and naturalistic outcome--comparisons with panic and major depressive disorders.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Follow-up and family study of anxious depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Mirtazapine in major depression with comorbid generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Mirtazapine in the treatment of panic disorder: an open-label trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Mirtazapine in social anxiety disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

A Trilogy Case Review Highlighting the Clinical and Pharmacologic Applications of Mirtazapine in Reducing Polypharmacy for Anxiety, Agitation, Insomnia, Depression, and Sexual Dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

SSRI adverse events: how to monitor and manage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2010.02624.X

21 January 2018

Identifiers

10.1111/J.1742-1241.2010.02624.X

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/21314870

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48912488&oldid=2138391782"